Trinity Biotech PLC (TRIB) SEC Filings — 2024

Filings

• Trinity Biotech Files 6-K for December 2024 — 6-K · Dec 27, 2024
• Trinity Biotech Files Routine 6-K Report — 6-K · Dec 26, 2024
• Trinity Biotech Files 6-K, Reports Under Form 20-F — 6-K · Dec 18, 2024
• Trinity Biotech Files Routine 6-K Report — 6-K · Dec 17, 2024
• Trinity Biotech PLC Files 6-K Report — 6-K · Nov 15, 2024
• Perceptive Advisors Amends Trinity Biotech Stake — SC 13D/A · Nov 14, 2024
• Trinity Biotech Regains Nasdaq Compliance — 6-K · Nov 7, 2024
• Trinity Biotech Acquires Prostate Cancer Test Developer EpiCapture — 6-K · Oct 25, 2024
• Trinity Biotech Announces Positive CGM Trial Results — 6-K · Oct 7, 2024
• Trinity Biotech Files 6-K Report — 6-K · Oct 2, 2024
• Trinity Biotech Files Routine 6-K Report — 6-K · Sep 30, 2024
• Trinity Biotech Acquires Metabolomics Diagnostics — 6-K · Sep 25, 2024
• Trinity Biotech Files Routine 6-K Report — 6-K · Sep 23, 2024
• Trinity Biotech PLC Updates Glucose Biosensor Technology Development — 6-K · Sep 19, 2024
• Trinity Biotech Updates Continuous Glucose Monitor Tech — 6-K · Sep 10, 2024
• Trinity Biotech plc Furnishes 2023 Annual Report — 6-K · Sep 5, 2024
• Trinity Biotech Appoints New Chief Commercial Officer — 6-K · Sep 4, 2024
• Trinity Biotech Files 6-K, Confirms 20-F Reporting — 6-K · Aug 29, 2024
• Trinity Biotech Secures Major TrinScreen HIV Orders — 6-K · Aug 27, 2024
• Trinity Biotech Files August 2024 6-K Report — 6-K · Aug 21, 2024
• Trinity Biotech PLC Files August 2024 6-K Report — 6-K · Aug 20, 2024
• Trinity Biotech Files 6-K for August Reporting — 6-K · Aug 7, 2024
• Trinity Biotech PLC Files 20-F/A Amendment — 20-F/A · Jul 12, 2024
• Trinity Biotech Files July 2024 Report (6-K) — 6-K · Jul 11, 2024
• Trinity Biotech Files Routine 6-K Report — 6-K · May 28, 2024
• Trinity Biotech Files Routine 6-K Report — 6-K · May 16, 2024
• Perceptive Advisors Amends Trinity Biotech Stake — SC 13D/A · May 1, 2024
• Trinity Biotech PLC Files 20-F Annual Report — 20-F · Apr 30, 2024
• Trinity Biotech Files Routine 6-K Report — 6-K · Apr 5, 2024
• Trinity Biotech Files Routine 6-K, Confirms 20-F Annual Reporting — 6-K · Feb 20, 2024
• Perceptive Advisors Discloses Significant Stake in Trinity Biotech — SC 13D · Feb 9, 2024
• Trinity Biotech to Acquire CGM Assets, Expanding Product Portfolio — 6-K · Feb 1, 2024
• MiCo Co., Ltd. Amends Trinity Biotech Stake, Ownership Details Updated — SC 13D/A · Jan 2, 2024
• Trinity Biotech Ships New HIV Test (TrinScreen HIV) to Kenya — 6-K · Jan 2, 2024